In conclusion, our findings highlight a modulation of CA III and CA IX expression in the crosstalk occurring between ACC and adipose stem cells, which might represent a putative target for the development of novel anticancer therapies directed against ACC adipose tumor microenvironment. The gene discussed is CA9; the disease is adrenal cortex carcinoma.